Cipla's Q3 FY 2025-26 Quarterly Results
- 24 Jan 2026
Result Summary
- Cipla Ltd reported a 7.3% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 0.2%.
- Its expenses for the quarter were up by 1.8% QoQ and 13.6% YoY.
- The net profit decreased 50.2% QoQ and decreased 57.2% YoY.
- The earnings per share (EPS) of Cipla Ltd stood at 8.36 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 7280.82 | 7858.39 | 7294.58 | -7.3% | -0.2% |
Total Expenses | 6111.80 | 6004.86 | 5378.49 | 1.8% | 13.6% |
Profit Before Tax | 893.11 | 1853.53 | 1916.09 | -51.8% | -53.4% |
Tax | 218.55 | 500.46 | 332.37 | -56.3% | -34.2% |
Profit After Tax | 674.25 | 1353.37 | 1574.59 | -50.2% | -57.2% |
Earnings Per Share | 8.36 | 16.72 | 0.00 | -50.0% | - |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Cipla Ltd is a renowned pharmaceutical company based in India, primarily engaged in the business of manufacturing and marketing pharmaceutical products and services. The company is well-known for its wide range of products in various therapeutic areas, including respiratory, anti-retroviral, urology, cardiology, anti-infective, and CNS segments, among others. Cipla has a significant global presence, with a focus on developing and delivering high-quality and affordable medicines. The company has been involved in various strategic initiatives to enhance its product offerings and expand its market reach. However, specific recent developments regarding strategic partnerships, acquisitions, or innovations have not been provided in the data.
Revenue
During Q3FY26, Cipla Ltd reported a total income of ₹7280.82 crores, reflecting a decrease of 7.3% compared to the previous quarter (Q2FY26), where total income was ₹7858.39 crores. Year-over-year, the total income saw a slight decline of 0.2% from ₹7294.58 crores in Q3FY25. The company's revenue performance indicates a marginal decline over the year, with more substantial contraction on a quarter-over-quarter basis. These figures highlight the revenue trends for the period under consideration, as provided in the data.
Profitability
The financial data for Cipla Ltd in Q3FY26 reveals a profit before tax (PBT) of ₹893.11 crores, which represents a significant decrease of 51.8% from the previous quarter (Q2FY26), where the PBT was ₹1853.53 crores. Year-over-year, the PBT also decreased by 53.4% from ₹1916.09 crores in Q3FY25. The profit after tax (PAT) for Q3FY26 was ₹674.25 crores, marking a decrease of 50.2% from Q2FY26 and a 57.2% decline from Q3FY25. Additionally, the earnings per share (EPS) for Q3FY26 stood at ₹8.36, down from ₹16.72 in Q2FY26. The decline in profitability metrics, both QoQ and YoY, is evident from the data, highlighting the changes in the company’s financial performance during the period.
Operating Metrics
Cipla Ltd's total expenses for Q3FY26 were reported at ₹6111.80 crores, showing an increase of 1.8% from ₹6004.86 crores in Q2FY26. Year-over-year, total expenses increased by 13.6% from ₹5378.49 crores in Q3FY25. The tax expenses for Q3FY26 amounted to ₹218.55 crores, reflecting a decrease of 56.3% from ₹500.46 crores in Q2FY26 and a 34.2% decline from ₹332.37 crores in Q3FY25. These metrics indicate changes in the operational costs and tax liabilities of the company over different periods, as noted in the data.